163 related articles for article (PubMed ID: 37577223)
41. Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction.
Wang Q; Wei S; Zhou S; Qiu J; Shi C; Liu R; Zhou H; Lu L
Immunol Cell Biol; 2020 Jan; 98(1):54-66. PubMed ID: 31625631
[TBL] [Abstract][Full Text] [Related]
42. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.
Liu Y; Lu T; Zhang C; Xu J; Xue Z; Busuttil RW; Xu N; Xia Q; Kupiec-Weglinski JW; Ji H
J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834
[TBL] [Abstract][Full Text] [Related]
43. Trans-anethole pretreatment ameliorates hepatic ischemia-reperfusion injury via regulation of soluble epoxide hydrolase.
Lu J; Hou W; Yang S; Chen D; Wang F; Liu L; Shen Z
Int Immunopharmacol; 2023 Nov; 124(Pt A):110809. PubMed ID: 37690240
[TBL] [Abstract][Full Text] [Related]
44. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
Front Immunol; 2022; 13():898799. PubMed ID: 36148239
[TBL] [Abstract][Full Text] [Related]
45. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
Zhu W; Feng PP; He K; Li SW; Gong JP
Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
[TBL] [Abstract][Full Text] [Related]
46. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
Sui YH; Luo WJ; Xu QY; Hua J
World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
[TBL] [Abstract][Full Text] [Related]
47. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
[TBL] [Abstract][Full Text] [Related]
48. FBXW5 aggravates hepatic ischemia/reperfusion injury via promoting phosphorylation of ASK1 in a TRAF6-dependent manner.
Li TT; Luo YH; Yang H; Chai H; Lei ZL; Peng DD; Wu ZJ; Huang ZT
Int Immunopharmacol; 2021 Oct; 99():107928. PubMed ID: 34217994
[TBL] [Abstract][Full Text] [Related]
49. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver.
Fujii T; Kuriyama N; Hayasaki A; Iizawa Y; Tanemura A; Kato H; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
Transplant Proc; 2018 Nov; 50(9):2807-2814. PubMed ID: 30401402
[TBL] [Abstract][Full Text] [Related]
50. Kupffer cell-targeting strategy for the protection of hepatic ischemia/reperfusion injury.
Dai Q; Jiang W; Liu H; Qing X; Wang G; Huang F; Yang Z; Wang C; Gu E; Zhao H; Zhang J; Liu X
Nanotechnology; 2021 Apr; 32(26):. PubMed ID: 33472187
[TBL] [Abstract][Full Text] [Related]
51. Liraglutide Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating Macrophage Polarization.
Li SL; Wang ZM; Xu C; Che FH; Hu XF; Cao R; Xie YN; Qiu Y; Shi HB; Liu B; Dai C; Yang J
Front Immunol; 2022; 13():869050. PubMed ID: 35450076
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
53. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
54. Emodin alleviates testicular ischemia-reperfusion injury through the inhibition of NLRP3-mediated pyroptosis.
He KX; Ning JZ; Li W; Cheng F
Tissue Cell; 2023 Jun; 82():102069. PubMed ID: 36921491
[TBL] [Abstract][Full Text] [Related]
55. Atractylenolide I Inhibits NLRP3 Inflammasome Activation in Colitis-Associated Colorectal Cancer
Qin Y; Yu Y; Yang C; Wang Z; Yang Y; Wang C; Zheng Q; Li D; Xu W
Front Pharmacol; 2021; 12():674340. PubMed ID: 34335248
[TBL] [Abstract][Full Text] [Related]
56. Deubiquitinase USP16 induces gouty arthritis via Drp1-dependent mitochondrial fission and NLRP3 inflammasome activation.
Wang Q; Qiu H
Arthritis Res Ther; 2023 Jul; 25(1):126. PubMed ID: 37488647
[TBL] [Abstract][Full Text] [Related]
57. Blocking GSDMD processing in innate immune cells but not in hepatocytes protects hepatic ischemia-reperfusion injury.
Li J; Zhao J; Xu M; Li M; Wang B; Qu X; Yu C; Hang H; Xia Q; Wu H; Sun X; Gu J; Kong X
Cell Death Dis; 2020 Apr; 11(4):244. PubMed ID: 32303674
[TBL] [Abstract][Full Text] [Related]
58. Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers.
Kang J; Liggett JR; Patil D; Ranjit S; Loh K; Duttargi A; Cui Y; Oza K; Frank BS; Kwon D; Kallakury B; Robson SC; Fishbein TM; Cui W; Khan K; Kroemer A
Front Immunol; 2022; 13():899525. PubMed ID: 35833123
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Mitochondrial Fission and NOX2 Expression Prevent NLRP3 Inflammasome Activation in the Endothelium: The Role of Corosolic Acid Action in the Amelioration of Endothelial Dysfunction.
Li Y; Zhou ZH; Chen MH; Yang J; Leng J; Cao GS; Xin GZ; Liu LF; Kou JP; Liu BL; Li P; Wen XD
Antioxid Redox Signal; 2016 Jun; 24(16):893-908. PubMed ID: 26869350
[TBL] [Abstract][Full Text] [Related]
60. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice.
Yang HJ; Tang LM; Zhou XJ; Qian J; Zhu J; Lu L; Wang XH
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):619-25. PubMed ID: 26663010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
